(Q34467816)

2 August 2017

title

Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences (English)

1 reference

2 August 2017

Else-Lydia Toverud

1

1 reference

2 August 2017

Anne Kjersti Røise

series ordinal

2

1 reference

2 August 2017

Grete Hogstad

series ordinal

3

1 reference

2 August 2017

Inger Wabø

series ordinal

4

1 reference

2 August 2017

publication date

23 November 2010

1 reference

European Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

67

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

33-38

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-010-0935-x

2 August 2017

exact match

0 references

cites work

Price control as a strategy for pharmaceutical cost containment - what has been achieved in Norway in the period 1994-2004?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016237

Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016237

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016237

How do patients evaluate the newly introduced system of substituting prescriptions?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016237

Patient compliance--an overview

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016237

The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016237

Pricing and reimbursement of drugs in Denmark.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016237

Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals

27 October 2018

1 reference

12 December 2020

Patients' attitudes towards and experiences of generic drug substitution in Norway

1 reference

12 December 2020

Generic substitution: additional challenge for adherence in hypertensive patients?

1 reference

12 December 2020

The way to economic prescribing

1 reference

12 December 2020

Consumer perceptions of risk and required cost savings for generic prescription drugs

1 reference

12 December 2020

Side effects of generic competition?

1 reference

12 December 2020

[Generic drugs instead of brand drugs prescriptions--long overdue]

1 reference

12 December 2020

Generic substitution: a potential risk factor for medication errors in hospitals

1 reference

12 December 2020

Generic substitution of antihypertensive drugs: does it affect adherence?

1 reference

12 December 2020

10.1007/S00228-010-0935-X

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference